Cargando…
Neoadjuvant Lorlatinib Induces Pathological Complete Response in Advanced ALK-Positive Lung Cancer: A Case Report
Patient: Male, 54-year-old Final Diagnosis: Lung adenocarcinoma Symptoms: Cough Clinical Procedure: — Specialty: Oncology • Pulmonology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Chemotherapy has been the conventional treatment method for advanced non-small-cell lung cancer (NS...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642716/ https://www.ncbi.nlm.nih.gov/pubmed/37934724 http://dx.doi.org/10.12659/AJCR.942150 |